La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Bon Natural Life Résultats passés
Passé contrôle des critères 2/6
Bon Natural Life has been growing earnings at an average annual rate of 23.3%, while the Chemicals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 18.9% per year. Bon Natural Life's return on equity is 12.7%, and it has net margins of 15.6%.
Informations clés
23.3%
Taux de croissance des bénéfices
10.1%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.9% |
| Taux de croissance des recettes | 18.9% |
| Rendement des fonds propres | 12.7% |
| Marge nette | 15.6% |
| Dernière mise à jour des bénéfices | 30 Sep 2023 |
Mises à jour récentes des performances passées
Recent updates
Bon Natural Life Limited's (NASDAQ:BON) Shares Not Telling The Full Story
Apr 30
Fewer Investors Than Expected Jumping On Bon Natural Life Limited (NASDAQ:BON)
Jan 27Bon Natural Life's (NASDAQ:BON) Returns Have Hit A Wall
Nov 13Returns on Capital Paint A Bright Future For Bon Natural Life (NASDAQ:BON)
Aug 15Why We Like The Returns At Bon Natural Life (NASDAQ:BON)
May 01The Returns At Bon Natural Life (NASDAQ:BON) Aren't Growing
Jan 16We Think That There Are Some Issues For Bon Natural Life (NASDAQ:BON) Beyond Its Promising Earnings
Aug 08Bon Natural Life GAAP EPS of $0.30, revenue of $13.7M
Aug 01Bon Natural Life (NASDAQ:BON) Is Experiencing Growth In Returns On Capital
Jun 24A Piece Of The Puzzle Missing From Bon Natural Life Limited's (NASDAQ:BON) 41% Share Price Climb
Mar 05Ventilation des recettes et des dépenses
Comment Bon Natural Life gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 23 | 30 | 5 | 3 | 0 |
| 30 Jun 23 | 30 | 5 | 3 | 0 |
| 31 Mar 23 | 30 | 6 | 3 | 0 |
| 31 Dec 22 | 30 | 6 | 3 | 0 |
| 30 Sep 22 | 30 | 6 | 2 | 0 |
| 30 Jun 22 | 29 | 6 | 2 | 0 |
| 31 Mar 22 | 27 | 5 | 2 | 0 |
| 31 Dec 21 | 26 | 5 | 2 | 0 |
| 30 Sep 21 | 25 | 5 | 1 | 0 |
| 30 Jun 21 | 24 | 4 | 1 | 0 |
| 31 Mar 21 | 23 | 4 | 1 | 0 |
| 31 Dec 20 | 20 | 3 | 1 | 0 |
| 30 Sep 20 | 18 | 3 | 2 | 0 |
| 30 Jun 20 | 17 | 3 | 1 | 0 |
| 31 Mar 20 | 15 | 3 | 1 | 0 |
| 31 Dec 19 | 16 | 3 | 1 | 1 |
| 30 Sep 19 | 16 | 3 | 2 | 1 |
| 30 Sep 18 | 11 | 0 | 1 | 1 |
Des revenus de qualité: BON has high quality earnings.
Augmentation de la marge bénéficiaire: BON's current net profit margins (15.6%) are lower than last year (20.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BON's earnings have grown significantly by 23.3% per year over the past 5 years.
Accélération de la croissance: BON's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: BON had negative earnings growth (-26.3%) over the past year, making it difficult to compare to the Chemicals industry average (-4.8%).
Rendement des fonds propres
ROE élevé: BON's Return on Equity (12.7%) is considered low.